FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113307947> ?p ?o ?g. }

• W2113307947 endingPage "39" @default.
• W2113307947 startingPage "33" @default.
• W2113307947 abstract "Over a million nonmelanoma skin cancer cases will be reported in the United States this year alone. Currently the primary form of treatment for these types of skin tumors is excision. However, excision of the initial lesion may not be curative because almost 50% of patients with one nonmelanoma skin cancer lesion develop another tumor within the next 5 yr at the site or adjacent to the site of excision. As with other types of epithelial based cancers, there is mounting evidence for the role of cyclooxygenase-2 (COX-2) and its products, particularly prostaglandin E(2) (PGE(2)), in the development of nonmelanoma skin cancer. To avoid the excision process, the present study was designed to evaluate the possible chemotherapeutic effect of directly treating established tumors with a topical formulation of the specific COX-2 inhibitor celecoxib. Skh/hr hairless mice were irradiated three times per wk for 16 wk to induce tumor formation. The mice were then divided into two groups and treated topically with either 500 microg celecoxib or the vehicle for 6 wk. Our results demonstrated that although topical treatment with celecoxib was not able to induce regression of established tumors, it did prevent new tumor formation after the onset of photocarcinogenesis. Although further studies are warranted, these data suggest that topical celecoxib treatment may prove to be effective in preventing the recurrence of tumors at the site of nonmelanoma skin cancer excision." @default.
• W2113307947 created "2016-06-24" @default.
• W2113307947 creator A5007246321 @default.
• W2113307947 creator A5007549562 @default.
• W2113307947 creator A5028866090 @default.
• W2113307947 creator A5037798038 @default.
• W2113307947 creator A5084160891 @default.
• W2113307947 date "2003-08-26" @default.
• W2113307947 modified "2023-10-17" @default.
• W2113307947 title "Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer" @default.
• W2113307947 cites W1648593433 @default.
• W2113307947 cites W1966167305 @default.
• W2113307947 cites W1970530787 @default.
• W2113307947 cites W1974630441 @default.
• W2113307947 cites W1988106534 @default.
• W2113307947 cites W1990747124 @default.
• W2113307947 cites W1994630764 @default.
• W2113307947 cites W1996174176 @default.
• W2113307947 cites W1998394615 @default.
• W2113307947 cites W2015022797 @default.
• W2113307947 cites W2035945839 @default.
• W2113307947 cites W2040528315 @default.
• W2113307947 cites W2048152958 @default.
• W2113307947 cites W2066265024 @default.
• W2113307947 cites W2068806248 @default.
• W2113307947 cites W2070609164 @default.
• W2113307947 cites W2109549744 @default.
• W2113307947 cites W2116688544 @default.
• W2113307947 cites W2126818734 @default.
• W2113307947 cites W2128100003 @default.
• W2113307947 cites W2129497878 @default.
• W2113307947 cites W2147666876 @default.
• W2113307947 cites W2149233326 @default.
• W2113307947 cites W2159973565 @default.
• W2113307947 cites W2336169581 @default.
• W2113307947 doi "https://doi.org/10.1002/mc.10142" @default.
• W2113307947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12949841" @default.
• W2113307947 hasPublicationYear "2003" @default.
• W2113307947 type Work @default.
• W2113307947 sameAs 2113307947 @default.
• W2113307947 citedByCount "45" @default.
• W2113307947 countsByYear W21133079472012 @default.
• W2113307947 countsByYear W21133079472013 @default.
• W2113307947 countsByYear W21133079472014 @default.
• W2113307947 countsByYear W21133079472018 @default.
• W2113307947 countsByYear W21133079472019 @default.
• W2113307947 countsByYear W21133079472020 @default.
• W2113307947 countsByYear W21133079472021 @default.
• W2113307947 crossrefType "journal-article" @default.
• W2113307947 hasAuthorship W2113307947A5007246321 @default.
• W2113307947 hasAuthorship W2113307947A5007549562 @default.
• W2113307947 hasAuthorship W2113307947A5028866090 @default.
• W2113307947 hasAuthorship W2113307947A5037798038 @default.
• W2113307947 hasAuthorship W2113307947A5084160891 @default.
• W2113307947 hasConcept C121608353 @default.
• W2113307947 hasConcept C126322002 @default.
• W2113307947 hasConcept C142724271 @default.
• W2113307947 hasConcept C16005928 @default.
• W2113307947 hasConcept C181199279 @default.
• W2113307947 hasConcept C2776467144 @default.
• W2113307947 hasConcept C2777789703 @default.
• W2113307947 hasConcept C2779156968 @default.
• W2113307947 hasConcept C2779689624 @default.
• W2113307947 hasConcept C2780664492 @default.
• W2113307947 hasConcept C2781156865 @default.
• W2113307947 hasConcept C2993162744 @default.
• W2113307947 hasConcept C502942594 @default.
• W2113307947 hasConcept C54355233 @default.
• W2113307947 hasConcept C55493867 @default.
• W2113307947 hasConcept C555283112 @default.
• W2113307947 hasConcept C71924100 @default.
• W2113307947 hasConcept C86803240 @default.
• W2113307947 hasConcept C98274493 @default.
• W2113307947 hasConceptScore W2113307947C121608353 @default.
• W2113307947 hasConceptScore W2113307947C126322002 @default.
• W2113307947 hasConceptScore W2113307947C142724271 @default.
• W2113307947 hasConceptScore W2113307947C16005928 @default.
• W2113307947 hasConceptScore W2113307947C181199279 @default.
• W2113307947 hasConceptScore W2113307947C2776467144 @default.
• W2113307947 hasConceptScore W2113307947C2777789703 @default.
• W2113307947 hasConceptScore W2113307947C2779156968 @default.
• W2113307947 hasConceptScore W2113307947C2779689624 @default.
• W2113307947 hasConceptScore W2113307947C2780664492 @default.
• W2113307947 hasConceptScore W2113307947C2781156865 @default.
• W2113307947 hasConceptScore W2113307947C2993162744 @default.
• W2113307947 hasConceptScore W2113307947C502942594 @default.
• W2113307947 hasConceptScore W2113307947C54355233 @default.
• W2113307947 hasConceptScore W2113307947C55493867 @default.
• W2113307947 hasConceptScore W2113307947C555283112 @default.
• W2113307947 hasConceptScore W2113307947C71924100 @default.
• W2113307947 hasConceptScore W2113307947C86803240 @default.
• W2113307947 hasConceptScore W2113307947C98274493 @default.
• W2113307947 hasIssue "1" @default.
• W2113307947 hasLocation W21133079471 @default.
• W2113307947 hasLocation W21133079472 @default.
• W2113307947 hasOpenAccess W2113307947 @default.
• W2113307947 hasPrimaryLocation W21133079471 @default.
• W2113307947 hasRelatedWork W1593721960 @default.

• next